IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
Clinical trial NCT07509086 · RECRUITING
Trial details
- NCT number
- NCT07509086
- Sponsor
- The First Hospital of Jilin University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-29
- Primary completion
- 2028-07-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.